Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 4
2018 4
2019 1
2020 1
2021 4
2022 2
2023 6
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Medical and surgical management of short bowel syndrome.
Billiauws L, Maggiori L, Joly F, Panis Y. Billiauws L, et al. J Visc Surg. 2018 Sep;155(4):283-291. doi: 10.1016/j.jviscsurg.2017.12.012. Epub 2018 Jul 21. J Visc Surg. 2018. PMID: 30041905 Free article. Review.
Emerging drugs for the treatment of short bowel syndrome.
Frau T, El Khatib M, De Dreuille B, Billiauws L, Nuzzo A, Joly F. Frau T, et al. Among authors: billiauws l. Expert Opin Emerg Drugs. 2024 Sep;29(3):277-288. doi: 10.1080/14728214.2024.2357567. Epub 2024 May 23. Expert Opin Emerg Drugs. 2024. PMID: 38761162 Review.
What's new in short bowel syndrome?
Billiauws L, Corcos O, Joly F. Billiauws L, et al. Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):313-318. doi: 10.1097/MCO.0000000000000473. Curr Opin Clin Nutr Metab Care. 2018. PMID: 29702489 Review.
Dysmotility disorders: a nutritional approach.
Billiauws L, Corcos O, Joly F. Billiauws L, et al. Curr Opin Clin Nutr Metab Care. 2014 Sep;17(5):483-8. doi: 10.1097/MCO.0000000000000095. Curr Opin Clin Nutr Metab Care. 2014. PMID: 25023191 Review.
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.
Uzzan M, Nachury M, Nuzzo A, Amiot A, Caron B, Benezech A, Buisson A, Bouguen G, Le Berre C, Reenaers C, Le Cosquer G, Savoye G, Charkaoui M, Vidon M, Guillo L, Fumery M, Peyrin-Biroulet L, Kirchgesner J, Bouhnik Y; GETAID TOFA-PRO study group. Uzzan M, et al. J Crohns Colitis. 2024 Mar 1;18(3):424-430. doi: 10.1093/ecco-jcc/jjad169. J Crohns Colitis. 2024. PMID: 37796025 Free article.
28 results